U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C28H33N7O2
Molecular Weight 502.6258
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Asandeutertinib

SMILES

[2H]C([2H])([2H])N1C=C(C2=C1C=CC=C2)C3=CC=NC(NC4=CC(NC(=O)C=C)=C(C=C4OC)N(C)CCN(C)C)=N3

InChI

InChIKey=DUYJMQONPNNFPI-VPYROQPTSA-N
InChI=1S/C28H33N7O2/c1-7-27(36)30-22-16-23(26(37-6)17-25(22)34(4)15-14-33(2)3)32-28-29-13-12-21(31-28)20-18-35(5)24-11-9-8-10-19(20)24/h7-13,16-18H,1,14-15H2,2-6H3,(H,30,36)(H,29,31,32)/i5D3

HIDE SMILES / InChI

Molecular Formula C28H33N7O2
Molecular Weight 502.6258
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Wed Apr 02 19:46:16 GMT 2025
Edited
by admin
on Wed Apr 02 19:46:16 GMT 2025
Record UNII
9EKD2E8BM5
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Osimertinib-d3
Preferred Name English
Asandeutertinib
INN  
Official Name English
asandeutertinib [INN]
Common Name English
2-Propenamide, N-[2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-[1-(methyl-d3)-1H-indol-3-yl]-2-pyrimidinyl]amino]phenyl]-
Systematic Name English
Code System Code Type Description
SMS_ID
300000054547
Created by admin on Wed Apr 02 19:46:16 GMT 2025 , Edited by admin on Wed Apr 02 19:46:16 GMT 2025
PRIMARY
CAS
1638281-46-5
Created by admin on Wed Apr 02 19:46:16 GMT 2025 , Edited by admin on Wed Apr 02 19:46:16 GMT 2025
PRIMARY
INN
12936
Created by admin on Wed Apr 02 19:46:16 GMT 2025 , Edited by admin on Wed Apr 02 19:46:16 GMT 2025
PRIMARY
PUBCHEM
87056175
Created by admin on Wed Apr 02 19:46:16 GMT 2025 , Edited by admin on Wed Apr 02 19:46:16 GMT 2025
PRIMARY
NCI_THESAURUS
C206877
Created by admin on Wed Apr 02 19:46:16 GMT 2025 , Edited by admin on Wed Apr 02 19:46:16 GMT 2025
PRIMARY
FDA UNII
9EKD2E8BM5
Created by admin on Wed Apr 02 19:46:16 GMT 2025 , Edited by admin on Wed Apr 02 19:46:16 GMT 2025
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
IRREVERSIBLE INHIBITOR
NON-LABELED -> LABELED
Related Record Type Details
METABOLITE ACTIVE -> PARENT
The AUC and Cmax of osimertinib increased sharply after deuteration. Systemic exposure of AZ5104 was remarkably reduced.
Related Record Type Details
ACTIVE MOIETY